Kraay AN - Search Results

1

Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies.

Shioda K, Lau MSY, Kraay ANM, Nelson KN, Siegler AJ, Sullivan PS, Collins MH, Weitz JS, Lopman BA. Shioda K, et al. Epidemiology. 2021 Jul 1;32(4):518-524. doi: 10.1097/EDE.0000000000001361. Epidemiology. 2021. PMID: 33935138 Free PMC article.

2

Considering indirect benefits is critical when evaluating SARS-CoV-2 vaccine candidates.

Gallagher ME, Sieben AJ, Nelson KN, Kraay ANM, Lopman B, Handel A, Koelle K. Gallagher ME, et al. medRxiv [Preprint]. 2020 Aug 11:2020.08.07.20170456. doi: 10.1101/2020.08.07.20170456. medRxiv. 2020. PMID: 32817958 Free PMC article. Updated. Preprint.

3

Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates.

Gallagher ME, Sieben AJ, Nelson KN, Kraay ANM, Orenstein WA, Lopman B, Handel A, Koelle K. Gallagher ME, et al. Nat Med. 2021 Jan;27(1):4-5. doi: 10.1038/s41591-020-01172-x. Nat Med. 2021. PMID: 33230343 Free PMC article. No abstract available.

4

Estimating the cumulative incidence of SARS-CoV-2 infection and the infection fatality ratio in light of waning antibodies.

Shioda K, Lau MS, Kraay AN, Nelson KN, Siegler AJ, Sullivan PS, Collins MH, Weitz JS, Lopman BA. Shioda K, et al. Among authors: kraay an. medRxiv [Preprint]. 2020 Nov 16:2020.11.13.20231266. doi: 10.1101/2020.11.13.20231266. medRxiv. 2020. PMID: 33236035 Free PMC article. Updated. Preprint.

5

Impact of Nonpharmaceutical Interventions for Severe Acute Respiratory Syndrome Coronavirus 2 on Norovirus Outbreaks: An Analysis of Outbreaks Reported By 9 US States.

Kraay ANM, Han P, Kambhampati AK, Wikswo ME, Mirza SA, Lopman BA. Kraay ANM, et al. J Infect Dis. 2021 Jul 2;224(1):9-13. doi: 10.1093/infdis/jiab093. J Infect Dis. 2021. PMID: 33606027 Free PMC article.

6

Risk for Fomite-Mediated Transmission of SARS-CoV-2 in Child Daycares, Schools, Nursing Homes, and Offices.

Kraay ANM, Hayashi MAL, Berendes DM, Sobolik JS, Leon JS, Lopman BA. Kraay ANM, et al. Emerg Infect Dis. 2021 Apr;27(4):1229-1231. doi: 10.3201/eid2704.203631. Emerg Infect Dis. 2021. PMID: 33755002 Free PMC article.

7

Modeling serological testing to inform relaxation of social distancing for COVID-19 control.

Kraay ANM, Nelson KN, Zhao CY, Demory D, Weitz JS, Lopman BA. Kraay ANM, et al. Nat Commun. 2021 Dec 3;12(1):7063. doi: 10.1038/s41467-021-26774-y. Nat Commun. 2021. PMID: 34862373 Free PMC article.

8

The role of booster vaccination and ongoing viral evolution in seasonal circulation of SARS-CoV-2.

Kraay ANM, Gallagher ME, Ge Y, Han P, Baker JM, Koelle K, Handel A, Lopman BA. Kraay ANM, et al. J R Soc Interface. 2022 Sep;19(194):20220477. doi: 10.1098/rsif.2022.0477. Epub 2022 Sep 7. J R Soc Interface. 2022. PMID: 36067790 Free PMC article.

9

Predicting the long-term impact of rotavirus vaccination in 112 countries from 2006 to 2034: A transmission modeling analysis.

Kraay ANM, Steele MK, Baker JM, Hall EW, Deshpande A, Saidzosa BF, Mukaratirwa A, Boula A, Mpabalwani EM, Kiulia NM, Tsolenyanu E, Enweronu-Laryea C, Abebe A, Beyene B, Tefera M, Willilo R, Batmunkh N, Pastore R, Mwenda JM, Antoni S, Cohen AL, Pitzer VE, Lopman BA. Kraay ANM, et al. Vaccine. 2022 Nov 2;40(46):6631-6639. doi: 10.1016/j.vaccine.2022.09.072. Epub 2022 Oct 6. Vaccine. 2022. PMID: 36210251 Free PMC article.

10

Predicting indirect effects of rotavirus vaccination programs on rotavirus mortality among children in 112 countries.

Kraay ANM, Chaney DM, Deshpande A, Pitzer VE, Lopman BA. Kraay ANM, et al. NPJ Vaccines. 2023 Mar 4;8(1):32. doi: 10.1038/s41541-023-00632-y. NPJ Vaccines. 2023. PMID: 36871093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page